Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis
Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study will be to evaluate the efficacy of topical ALT-2074
applied twice daily for 28 days for treatment of chronic plaque psoriasis in adult subjects.
The secondary objective will be to evaluate the safety of topical ALT-2074 applied twice
daily for 28 days for treatment of chronic plaque psoriasis in adult subjects.
Tertiary objectives will be to provide visual documentation of the improvement of psoriatic
plaques treated with ALT-2074 using digital photography, and to determine the extent of
systemic absorption of topically applied ALT-2074 based on a pharmacokinetic measurement of
blood concentration.